We are growing quickly and looking for talented people to fill our current openings in Commercial, R&D, Corporate, Software, and Operations. ... You will join other employees, who are taking exciting first steps in their own careers, and create a community of support. Highly tunable data output to run virtually any genome, sequencing method, and scale of projectA rapid, single-day solution for analyzing the coding transcriptome leveraging as little as 25 ng input of standard (non-degraded) RNA.Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare diseaseFast, high-quality, sample-to-data services such as RNA and whole-genome sequencingWhole-genome shotgun sequencing and transcriptomics provide data to refine drug discovery and developmentWhole-genome shotgun sequencing and transcriptomics provide data to refine drug discovery and developmentWhole-genome shotgun sequencing and transcriptomics provide data to refine drug discovery and developmentWhole-genome shotgun sequencing and transcriptomics provide data to refine drug discovery and developmentWhole-genome shotgun sequencing and transcriptomics provide data to refine drug discovery and developmentWhole-genome shotgun sequencing and transcriptomics provide data to refine drug discovery and developmentTruSight Software Suite accelerates identification of genetic diseasesTruSight Software Suite accelerates identification of genetic diseasesTruSight Software Suite accelerates identification of genetic diseasesTruSight Software Suite accelerates identification of genetic diseasesTruSight Software Suite accelerates identification of genetic diseasesTruSight Software Suite accelerates identification of genetic diseasesThree approaches to help researchers with sequencing Three approaches to help researchers with sequencing Three approaches to help researchers with sequencing Three approaches to help researchers with sequencing Three approaches to help researchers with sequencing Three approaches to help researchers with sequencing Expanded portfolio enables comprehensive genomic profiling from blood and tissueExpanded portfolio enables comprehensive genomic profiling from blood and tissueExpanded portfolio enables comprehensive genomic profiling from blood and tissueExpanded portfolio enables comprehensive genomic profiling from blood and tissueExpanded portfolio enables comprehensive genomic profiling from blood and tissueA culture-free method for studying complex microbiomes or environmentsA culture-free method for studying complex microbiomes or environmentsA culture-free method for studying complex microbiomes or environmentsA culture-free method for studying complex microbiomes or environmentsA culture-free method for studying complex microbiomes or environmentsA highly sensitive and accurate tool for measuring expression across the transcriptomeA highly sensitive and accurate tool for measuring expression across the transcriptomeA highly sensitive and accurate tool for measuring expression across the transcriptomeA highly sensitive and accurate tool for measuring expression across the transcriptomeA highly sensitive and accurate tool for measuring expression across the transcriptomeTruSight Software Suite accelerates the identification of genetic diseasesTruSight Software Suite accelerates the identification of genetic diseasesTruSight Software Suite accelerates the identification of genetic diseasesTruSight Software Suite accelerates the identification of genetic diseasesTruSight Software Suite accelerates the identification of genetic diseasesA culture-free method for studying complex microbiomes or environmentsA culture-free method for studying complex microbiomes or environmentsA culture-free method for studying complex microbiomes or environmentsA culture-free method for studying complex microbiomes or environmentsA culture-free method for studying complex microbiomes or environmentsStudy gene expression changes in cancer, RNA biomarkers of drug response, and moreStudy gene expression changes in cancer, RNA biomarkers of drug response, and moreStudy gene expression changes in cancer, RNA biomarkers of drug response, and moreStudy gene expression changes in cancer, RNA biomarkers of drug response, and moreTruSight Software Suite accelerates the identification of genetic diseasesTruSight Software Suite accelerates the identification of genetic diseasesTruSight Software Suite accelerates the identification of genetic diseasesTruSight Software Suite accelerates the identification of genetic diseasesAt Illumina, we push boundaries. Experience the breathtaking pace of genomic innovation through Illumina internship opportunities. Illumina is an equal opportunity employer and is committed to a diverse workforce. You are encouraged to sustain work:life balance and are provided programs geared towards keeping employees healthy. If you are unable or limited in your ability to use or access Illumina's career website as a result of your disability, you may visit our accessible At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Explore Biotech Internships at Illumina. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.All trademarks are the property of Illumina, Inc. or their respective owners.This is the international website for Illumina. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. have mastered your current level.There is no “normal” here.
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.All trademarks are the property of Illumina, Inc. or their respective owners.This is the international website for Illumina.